Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
Abstract
Nanotechnology-based RNA interference (RNAi) has shown great promise in overcoming the limitations of traditional clinical treatments for glioblastoma (GBM). However, because of the complexity of brain physiology, simple blood-brain barrier (BBB) penetration or tumor-targeting strategies cannot entirely meet the demanding requirements of different therapeutic delivery stages. Herein, we developed a charge conversional biomimetic nanoplatform with a three-layer core-shell structure to programmatically overcome persistent obstacles in siRNA delivery to GBM. The resulting nanocomplex presents good biocompatibility, prolonged blood circulation, high BBB transcytosis, effective tumor accumulation, and specific uptake by tumor cells in the brain. Moreover, red blood cell membrane (RBCm) disruption and effective siRNA release can be further triggered elegantly by charge conversion from negative to positive in the endo/lysosome (pH 5.0-6.5) of tumor cells, leading to highly potent target-gene silencing with a strong anti-GBM effect. Our study provides an intelligent biomimetic nanoplatform tailored for systemically siRNA delivery to GBM, leveraging Angiopep-2 peptide-modified, immune-free RBCm and charge conversional components. Improved therapeutic efficacy, higher survival rates, and minimized systemic side effects were achieved in orthotopic U87MG-luc human glioblastoma tumor-bearing nude mice.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ang-RBCm-CA/siRNA can penetrate the blood-brain barrier and enhance the accumulation and retention of siRNA in tumors.
“This functionalized nanocomposite can penetrate through the blood-brain barrier and enhance the accumulation and retention of SiRNA in tumors.”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [221]
Cites
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,449 · see citing works
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220 · see citing works
Self-citationBlood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102 · see citing works
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670 · see citing works
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,509 · see citing works
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204 · see citing works
Glioblastoma stem-like cells give rise to tumour endothelium
Wang, R., Chadalavada, K., Wilshire, J. A., Kowalik, U., Hovinga, K. E., Geber, A. B., Fligelman, B., Leversha, M. A., Brennan, C., & Tabar, V. S. (2010) · Nature · doi:10.1038/nature09624 · Cited by 1,203 · see citing works
Xue, J., Zhao, Z., Zhang, L., Xue, L., Shen, S., Wen, Y., Wei, Z., Wang, L., Kong, L., Sun, H., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.54 · Cited by 955 · see citing works
Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Lipsman, N., Meng, Y., Bethune, A. J., Huang, Y., Lam, B., Masellis, M., Herrmann, N., Heyn, C., Aubert, I., Boutet, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04529-6 · Cited by 950 · see citing works
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A. G., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 847 · see citing works
Kioi, M., Vogel, H. S., Schultz, G. M., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 775 · see citing works
Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization
Dehaini, D., Wei, X., Fang, R. H., Masson, S., Angsantikul, P., Luk, B. T., Zhang, Y., Man, Y. M., Jiang, Y., Kroll, A. V., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606209 · Cited by 775 · see citing works
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C. J., Fang, R. H., Copp, J. A., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 755 · see citing works
Yi, H.-G., Jeong, Y. H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0363-x · Cited by 634 · see citing works
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592 · see citing works
Current and future strategies for treatment of glioma
Bush, N. A. O., Chang, S. M., & Berger, M. S. (2016) · Neurosurgical Review · doi:10.1007/s10143-016-0709-8 · Cited by 584 · see citing works
Lin, T., Zhao, P., Jiang, Y., Tang, Y., Jin, H., Pan, Z., He, H., Yang, V. C.-M., & Huang, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b04268 · Cited by 533 · see citing works
A Protein Nanocarrier from Charge-Conversion Polymer in Response to Endosomal pH
Lee, Y., Fukushima, S., Bae, Y., Hiki, S., Ishii, T., & Kataoka, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071090b · Cited by 405 · see citing works
Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
Fan, K., Jia, X., Zhou, M., Wang, K., Conde, J., He, J., Tian, J., & Yan, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b06969 · Cited by 398 · see citing works
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Hu, C. J., Fang, R. H., Dehaini, D., Carpenter, C. W., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 377 · see citing works
Nanoparticle-detained toxins for safe and effective vaccination
Hu, C. J., Fang, R. H., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.254 · Cited by 342 · see citing works
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Chen, X., Zhang, M., Gan, H., Wang, H., Lee, J., Fang, D., Kitange, G. J., He, L., Hu, Z., Parney, I. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05373-4 · Cited by 270 · see citing works
Arvanitis, C., Askoxylakis, V., Guo, Y., Datta, M., Kloepper, J., Ferraro, G. B., Bernabéu, M. O., Fukumura, D., McDannold, N. J., & Jain, R. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807105115 · Cited by 235 · see citing works
A Crosslinked Nucleic Acid Nanogel for Effective siRNA Delivery and Antitumor Therapy
Ding, F., Mou, Q., Ma, Y., Pan, G., Guo, Y., Tong, G., Choi, C. H. J., Zhu, X., & Zhang, C. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711242 · Cited by 226 · see citing works
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Alexander, B. M., Ba, S., Berger, M. S., Berry, D. A., Cavenee, W. K., Chang, S. M., Cloughesy, T. F., Jiang, T., Khasraw, M., Li, W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0764 · Cited by 225 · see citing works
Su, J., Sun, H., Meng, Q., Yin, Q., Tang, S., Zhang, P., Chen, Y., Zhang, Z., Yu, H., & Li, Y. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504780 · Cited by 223 · see citing works
Comparison of glioblastoma (GBM) molecular classification methods
Lee, E., Yong, R. L. M., Paddison, P. J., & Zhu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.006 · Cited by 215 · see citing works
Huang, J., Jiang, G., Song, Q., Gu, X. Q., Meng, H., Wang, X.-L., Song, H., Chen, L., Lin, Y., Jiang, D. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15144 · Cited by 211 · see citing works
Nanotechnology-based strategies for siRNA brain delivery for disease therapy
Zheng, M., Tao, W., Zou, Y., Farokhzad, O. C., & Shi, B. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.01.006 · Cited by 210 · see citing works
Self-citationRadiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy
Erel‐Akbaba, G., de Carvalho, L. A., Tian, T., Zinter, M., Akbaba, H., Obeid, P. J., Chiocca, E. A., Weissleder, R., Kantarcı, A. G., & Tannous, B. A. (2019) · ACS Nano · doi:10.1021/acsnano.8b08177 · Cited by 205 · see citing works
Zou, Y., Liu, Y., Yang, Z., Zhang, D., Lu, Y., Zheng, M., Xue, X., Geng, J., Chung, R., & Shi, B. (2018) · Advanced Materials · doi:10.1002/adma.201803717 · Cited by 203 · see citing works
Self-citationQiao, C.-M., Yang, J., Shen, Q., Liu, R., Li, Y., Shi, Y., Chen, J., Shen, Y., Xiao, Z., Weng, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201705054 · Cited by 179 · see citing works
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
Zhao, Y. D., Wang, W., Guo, S., Wang, Y., Miao, L., Xiong, Y., & Huang, L. (2016) · Nature Communications · doi:10.1038/ncomms11822 · Cited by 171 · see citing works
Jiang, Y., Yang, W., Zhang, J., Meng, F., & Zhong, Z. (2018) · Advanced Materials · doi:10.1002/adma.201800316 · Cited by 164 · see citing works
López-Bertoni, H., Kozielski, K., Rui, Y., Lal, B., Vaughan, H. J., Wilson, D. R., Mihelson, N., Eberhart, C. G., Laterra, J., & Green, J. J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00390 · Cited by 164 · see citing works
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide
Murphy, S. F., Varghese, R. T., Lamouille, S., Guo, S., Pridham, K. J., Kanabur, P., Osimani, A. M., Sharma, S., Jourdan, J., Rodgers, C. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1286 · Cited by 163 · see citing works
Stegh, A. H., Kesari, S., Mahoney, J. E., Jenq, H. T., Forloney, K. L., Protopopov, A. I., Louis, D. N., Chin, L., & DePinho, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712034105 · Cited by 141 · see citing works
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers
Miteva, M., Kirkbride, K. C., Kilchrist, K. V., Werfel, T. A., Li, H., Nelson, C. E., Gupta, M. K., Giorgio, T. D., & Duvall, C. L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.036 · Cited by 140 · see citing works
Saw, P. E., Yao, H., Lin, C., Tao, W., Farokhzad, O. C., & Xu, X. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01660 · Cited by 138 · see citing works
Self-citationDual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells
Kim, J. S., Shin, D. H., & Kim, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.026 · Cited by 133 · see citing works
Yu, D., Khan, O. F., Suvà, M. L., Dong, B., Panek, W. K., Xiao, T., Wu, M., Han, Y., Ahmed, A. U., Balyasnikova, I. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701911114 · Cited by 122 · see citing works
A TNF–JNK–Axl–ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma
Guo, G., Gong, K., Ali, S., Ali, N., Shallwani, S., Hatanpaa, K. J., Pan, E., Mickey, B., Burma, S., Wang, D. H., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4584 · Cited by 114 · see citing works
Danhier, F., Messaoudi, K., Lemaire, L. P., Benoît, J., & Lagarce, F. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.051 · Cited by 103 · see citing works
Suryaprakash, S., Lao, Y., Cho, H., Li, M., Ji, H. Y., Shao, D., Hu, H., Quek, C. H., Huang, D., Mintz, R. L., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04697 · Cited by 96 · see citing works
A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery
Ruan, H., Chai, Z., Shen, Q., Chen, X., Su, B., Xie, C., Zhan, C., Yao, S., Wang, H., Zhang, M., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.035 · Cited by 91 · see citing works
The siRNAsome: A Cation‐Free and Versatile Nanostructure for siRNA and Drug Co‐delivery
Zheng, M., Jiang, T., Yang, W., Zou, Y., Wu, H., Liu, X., Zhu, F., Qian, R., Ling, D., McDonald, K. L., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814289 · Cited by 88 · see citing works
Self-citationMantle, J. L., Min, L., & Lee, K. H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00818 · Cited by 87 · see citing works
Shape and Interhelical Spacing of DNA Origami Nanostructures Studied by Small-Angle X-ray Scattering
Fischer, S., Hartl, C., Frank, K., Rädler, J. O., Liedl, T., & Nickel, B. A. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01335 · Cited by 84 · see citing works
Nicoli, F., Barth, A., Bae, W., Neukirchinger, F., Crevenna, Á. H., Lamb, D. C., & Liedl, T. (2017) · ACS Nano · doi:10.1021/acsnano.7b05631 · Cited by 84 · see citing works
A ribonucleoprotein octamer for targeted siRNA delivery
Tai, W., Li, J., Corey, E., & Gao, X. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0214-1 · Cited by 79 · see citing works
Mittal, S., Klinger, N. V., Michelhaugh, S. K., Barger, G. R., Pannullo, S. C., & Juhász, C. (2017) · Journal of neurosurgery · doi:10.3171/2016.9.jns16452 · Cited by 66 · see citing works
Different molecular patterns in glioblastoma multiforme subtypes upon recurrence
Martínez, R., Rohde, V., & Schackert, G. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9967-4 · Cited by 65 · see citing works
He, S., Fan, W., Wu, N., Zhu, J., Miao, Y., Miao, X., Li, F., Zhang, X., & Gan, Y. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05430 · Cited by 59 · see citing works
Real-Time Visualization of Nanoparticles Interacting with Glioblastoma Stem Cells
Pohlmann, E. S., Patel, K., Guo, S., Dukes, M. J., Sheng, Z., & Kelly, D. F. (2015) · Nano Letters · doi:10.1021/nl504481k · Cited by 57 · see citing works
Transferrin-Appended Nanocaplet for Transcellular siRNA Delivery into Deep Tissues
Kohata, A., Hashim, P. K., Okuro, K., & Aida, T. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b12501 · Cited by 57 · see citing works
Efficient siRNA delivery with non-cationic carriers
Choi, C. K. K., Zhang, L., & Choi, C. H. J. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0240-z · Cited by 32 · see citing works
Acid‐Labile Acyclic Cucurbit[n]uril Molecular Containers for Controlled Release
Mao, D., Liang, Y., Liu, Y., Zhou, X., Ma, J., Jiang, B., Liu, J., & Ma, D. (2017) · Angewandte Chemie · doi:10.1002/ange.201707164 · Cited by 22 · see citing works
Self-citationPatient-specific 3D-printed glioblastomas
Gomez-Roman, N., & Chalmers, A. J. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0379-2 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586 · see citing works
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332 · see citing works
Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268 · see citing works
Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy
Zou, Y., Wang, Y., Xu, S., Liu, Y., Yin, J., Lovejoy, D. B., Zheng, M., Liang, X., Park, J. B., Efremov, Y. M., et al. (2022) · Advanced Materials · doi:10.1002/adma.202203958 · Cited by 204 · see citing works
Self-citationZheng, M., Pan, M., Zhang, W., Lin, H., Wu, S., Lu, C. T., Tang, S., Liu, D., & Cai, J. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.001 · Cited by 196 · see citing works
Self-citationRuan, S., Zhou, Y., Jiang, X., & Gao, H. (2021) · Advanced Science · doi:10.1002/advs.202004025 · Cited by 195 · see citing works
Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy
Zhang, Q., Kuang, G., Li, W., Wang, J., Ren, H., & Zhao, Y. (2023) · Nano-Micro Letters · doi:10.1007/s40820-023-01018-4 · Cited by 190 · see citing works
Zou, Y., Sun, Y., Wang, Y., Zhang, D., Yang, H., Wang, X., Zheng, M., & Shi, B. (2023) · Nature Communications · doi:10.1038/s41467-023-40280-3 · Cited by 189 · see citing works
Self-citationNanotechnology-based drug delivery for central nervous system disorders
Nguyen, T. T., Nguyen, T. T. D., Vo, T. K., An, T. N. M., Nguyen, M. K., Toi, V. V., & Vo, G. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112117 · Cited by 181 · see citing works
Wang, J., Liu, Y., Morsch, M., Lu, Y., Shangguan, P., Han, L., Wang, Z., Chen, X., Song, C., Liu, S., et al. (2022) · Advanced Materials · doi:10.1002/adma.202106082 · Cited by 163 · see citing works
Self-citationEnhancing immunotherapy with tumour-responsive nanomaterials
Linderman, S. W., DeRidder, L. B., Sanjurjo, L., Foote, M. B., Alonso, M. J., Kirtane, A. R., Langer, R., & Traverso, G. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01000-6 · Cited by 163 · see citing works
Fu, X., Shi, Y., Qi, T., Qiu, S., Huang, Y., Zhao, X., Sun, Q., & Lin, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00342-0 · Cited by 146 · see citing works
Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review
Habib, S., & Singh, M. (2022) · Polymers · doi:10.3390/polym14040712 · Cited by 137 · see citing works
Zhang, W. Y., Gong, C., Chen, K., Li, M., Li, Y., & Gao, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01085-y · Cited by 123 · see citing works
Liu, Y., Wang, W., Zhang, D., Sun, Y., Li, F., Zheng, M., Lovejoy, D. B., Zou, Y., & Shi, B. (2022) · Exploration · doi:10.1002/exp.20210274 · Cited by 120 · see citing works
Self-citationHussain, Z., Rahim, M. A., Jan, N., Shah, H., Rawas‐Qalaji, M., Khan, S., Sohail, M. F., Thu, H. E., Ramli, N. A., Sarfraz, R. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.018 · Cited by 119 · see citing works
Mu, R., Zhu, D., Abdulmalik, S., Wijekoon, S., Wei, G., & Kumbar, S. G. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.01.023 · Cited by 119 · see citing works
Jiang, T., Qiao, Y., Ruan, W., Zhang, D., Yang, Q., Wang, G., Chen, Q., Zhu, F., Yin, J., Zou, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202104779 · Cited by 116 · see citing works
Self-citationHe, W., Li, X., Morsch, M., Ismail, M., Liu, Y., Rehman, F. U., Zhang, D., Wang, Y., Zheng, M., Chung, R. S., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00320 · Cited by 116 · see citing works
Self-citationGlioma diagnosis and therapy: Current challenges and nanomaterial-based solutions
Li, T., Li, J., Chen, Z., Zhang, S., Li, S., Wageh, S., Al‐Hartomy, O. A., Al-Sehemi, A. G., Xie, Z., Kankala, R. K., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.065 · Cited by 110 · see citing works
Zhang, M., Wang, W., Mohammadniaei, M., Zheng, T., Zhang, Q., Ashley, J. A., Liu, S., Sun, Y., & Tang, B. Z. (2021) · Advanced Materials · doi:10.1002/adma.202008802 · Cited by 103 · see citing works
Tiwari, P., Yadav, D. K., Shukla, R. P., Gautam, S., Marwaha, D., Sharma, M., & Mishra, P. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.016 · Cited by 88 · see citing works
Chen, H., Zhou, M., Zeng, Y., Miao, T., Luo, H., Tong, Y., Zhao, M., Mu, R., Gu, J., Yang, S.-D., et al. (2022) · Advanced Science · doi:10.1002/advs.202105854 · Cited by 83 · see citing works
Design of polymers for siRNA delivery: Recent progress and challenges
Wang, H., Zhang, S., Lv, J., & Cheng, Y. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200026 · Cited by 78 · see citing works
Nanomedicine-based immunotherapy for central nervous system disorders
Hanif, S., Muhammad, P., Chesworth, R., Rehman, F. U., Qian, R., Zheng, M., & Shi, B. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0429-z · Cited by 68 · see citing works
Self-citationBiomedical applications of stimuli‐responsive nanomaterials
Chen, X., Wu, D., & Chen, Z. (2024) · MedComm · doi:10.1002/mco2.643 · Cited by 66 · see citing works
New Drug Delivery Systems Developed for Brain Targeting
Rawal, S. U., Patel, B. M., & Patel, M. M. (2022) · Drugs · doi:10.1007/s40265-022-01717-z · Cited by 65 · see citing works
Liu, Y., Zheng, M., Jiao, M., Yan, C., Xu, S., Du, Q., Morsch, M., Yin, J., & Shi, B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121036 · Cited by 64 · see citing works
Self-citationNanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies
Karlsson, J. E., Luly, K. M., Tzeng, S. Y., & Green, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113999 · Cited by 63 · see citing works
Yang, J., Duan, S., Ye, H., Ge, C., Piao, C., Chen, Y., Lee, M., & Yin, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008960 · Cited by 61 · see citing works
Deng, Y., Zhou, Y., Liang, Q., Ge, C., Yang, J., Shan, B., Liu, Y., Zhou, X., & Yin, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202101033 · Cited by 61 · see citing works
Self-citationGuo, Y., Cao, X., Zheng, X., Abbas, S. J., Li, J., & Tan, W. (2022) · National Science Review · doi:10.1093/nsr/nwac006 · Cited by 61 · see citing works
Wang, M., Zhang, L., Cai, Y., Yang, Y., Qiu, L., Shen, Y., Jin, J., Zhou, J., & Chen, J. (2020) · ACS Nano · doi:10.1021/acsnano.0c07610 · Cited by 60 · see citing works
Immunological nanomaterials to combat cancer metastasis
Pan, Y., Cheng, J., Zhu, Y., Zhang, J., Fan, W., & Chen, X. S. (2024) · Chemical Society Reviews · doi:10.1039/d2cs00968d · Cited by 58 · see citing works
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Branco, F., Cunha, J., Mendes, M., Vitorino, C., & Sousa, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c01790 · Cited by 58 · see citing works
A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy
Peng, J., Chen, F., Liu, Y., Zhang, F., Cao, L., You, Q., Yang, D., Chang, Z., Ge, M., Li, L., et al. (2022) · Theranostics · doi:10.7150/thno.68756 · Cited by 58 · see citing works
Self-citationIsmail, M., Yang, W., Li, Y., Wang, Y., He, W., Wang, J., Muhammad, P., Chaston, T. B., Rehman, F. U., Zheng, M., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121760 · Cited by 57 · see citing works
Self-citationZhang, Y., Ma, H., Li, L.-S., Sun, C., Yu, C., Wang, L., Xu, D., Song, X., & Yu, R. (2024) · Advanced Materials · doi:10.1002/adma.202400502 · Cited by 57 · see citing works
Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 56 · see citing works
Li, H., Ding, Y., Huang, J., Zhao, Y., Chen, W., Tang, Q., An, Y., Chen, R., & Hu, C. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s395246 · Cited by 55 · see citing works
Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Nguyen, T. T., Nguyen, T. T. D., An, T. N. M., & Giau, V. V. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03488-7 · Cited by 52 · see citing works
Cancer nanomedicine based on polyethylenimine-mediated multifunctional nanosystems
Li, J., Yu, X., Shi, X., & Shen, M. (2021) · Progress in Materials Science · doi:10.1016/j.pmatsci.2021.100871 · Cited by 51 · see citing works
Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma
Liu, Y., Zhang, D., An, Y., Sun, Y., Li, J., Zheng, M., Zou, Y., & Shi, B. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101790 · Cited by 51 · see citing works
Self-citationStimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma
Ismail, M., Wang, Y., Li, Y., Liu, J., Zheng, M., & Zou, Y. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00722 · Cited by 51 · see citing works
Self-citationWei, Y., Xia, X., Li, H., & Gao, H. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2245332 · Cited by 50 · see citing works
Susa, F., Arpicco, S., Pirri, C. F., & Limongi, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070849 · Cited by 50 · see citing works
Zhou, L., Pi, W., Hao, M., Li, Y., An, H., Li, Q., Zhang, P., & Wen, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm00568e · Cited by 49 · see citing works
Chang, M., Dong, C., Huang, H., Ding, L., Feng, W., & Chen, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204791 · Cited by 49 · see citing works
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Guo, Z.-H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C., Wu, D., & Ji, X. (2023) · Molecules · doi:10.3390/molecules28031283 · Cited by 49 · see citing works
Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport
Lenders, V., Koutsoumpou, X., Phan, P., Soenen, S. J., Allegaert, K., Vleeschouwer, S. D., Toelen, J., Zhao, Z., & Manshian, B. B. (2023) · Chemical Society Reviews · doi:10.1039/d1cs00574j · Cited by 49 · see citing works
Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas
Cui, J., Xu, Y., Tu, H., Zhao, H., Wang, H., Di, L., & Wang, R. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.013 · Cited by 47 · see citing works
MicroRNA Schizophrenia: Etiology, Biomarkers and Therapeutic Targets.
Zhang, H., Du, Y., Chen, L., Yuan, Z.-Q., & Cheng, Y. (2023) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105064 · Cited by 43 · see citing works
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy
Kumari, S., Gupta, R. V., Ambasta, R. K., & Kumar, P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188913 · Cited by 47 · see citing works
Nanoparticles with transformable physicochemical properties for overcoming biological barriers
Lu, Q., Yu, H., Zhao, T., Zhu, G., & Li, X. (2023) · Nanoscale · doi:10.1039/d3nr01332d · Cited by 46 · see citing works
Tuning the Elasticity of Polymersomes for Brain Tumor Targeting
Zheng, M., Du, Q., Wang, X., Zhou, Y., Li, J., Xia, X., Lu, Y., Yin, J., Zou, Y., Park, J. B., et al. (2021) · Advanced Science · doi:10.1002/advs.202102001 · Cited by 46 · see citing works
Self-citationNanotechnology‐Based Strategies for Early Diagnosis of Central Nervous System Disorders
Hanif, S., Muhammad, P., Niu, Z., Ismail, M., Morsch, M., Zhang, X., Li, M., & Shi, B. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100008 · Cited by 44 · see citing works
Self-citationNucleic acid-based therapy for brain cancer: Challenges and strategies
Zhang, Z., Conniot, J., Amorim, J., Jin, Y., Prasad, R., Yan, X., Fan, K., & Conde, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.014 · Cited by 43 · see citing works
Wang, R., Wang, X., Li, J., Di, L., Zhou, J., & Ding, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.10.039 · Cited by 43 · see citing works
Pang, Q., Xu, Z., Sun, T., Yue, S., Yu, Y., Lu, H., He, M., Chen, X., Lu, Y., & Li, J. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102421 · Cited by 42 · see citing works
Lu, L., Wang, K., Lin, C., Yang, W., Duan, Q., Li, K., & Cai, K. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121193 · Cited by 41 · see citing works
Luo, K., Lian, Y., Zhang, M., Yu, H., Wang, G., & Li, J. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.128659 · Cited by 40 · see citing works
ROS-responsive polypeptides for intracellular protein delivery and CRISPR/Cas9 gene editing
Tan, E., Wan, T. Y., Yu, C., Fan, Q., Liu, W., Chang, H., Lv, J., Wang, H., Li, D., Yuan, P., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101617 · Cited by 36 · see citing works
Akhter, M. H., Rizwanullah, M., Ahmad, J., Amin, S., Ahmad, M. Z., Minhaj, M. A., Mujtaba, M. A., & Ali, J. (2020) · Drug Research · doi:10.1055/a-1296-7870 · Cited by 35 · see citing works
Inactive Trojan Bacteria as Safe Drug Delivery Vehicles Crossing the Blood–Brain Barrier
Lu, J., Ding, J., Chu, B., Ji, C., Zhang, Q., Xu, Y., Song, B., Wang, H., & He, Y. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00563 · Cited by 35 · see citing works
Hao, J., Li, Y., Huang, L., Qi, N., Sun, Y., He, C., Yang, S., Niu, Z.-Y., Qi, X., & Xiang, B. (2025) · Theranostics · doi:10.7150/thno.112492 · Cited by 32 · see citing works
Yan, J., Meng, W., Shan, H., Zhang, X., Zou, L.-M., Wang, L., Shi, J., & Kong, X. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c02916 · Cited by 31 · see citing works
Song, B., Wang, X., Qin, L., Hussain, S., & Liang, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107308 · Cited by 30 · see citing works
Li, Y., Xie, M., Jones, J. B., Zhang, Z., Wang, Z., Dang, M. T., Wang, X., Lipowska, M., & Mao, H. Z. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102816 · Cited by 30 · see citing works
Sharma, R. K., Calderon, C., & Vivas‐Mejía, P. E. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.678593 · Cited by 28 · see citing works
Brain targeted biomimetic siRNA nanoparticles for drug resistance glioblastoma treatment
Li, S., Li, X., Wang, N., Zhang, C., Sang, Y., Sun, Y., Xia, X., & Zheng, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.004 · Cited by 27 · see citing works
Self-citationNature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases
Ji, W., Li, Y., Peng, H., Zhao, R., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114029 · Cited by 27 · see citing works
Construction of Nanocarriers Based on Endogenous Cell Membrane and Their Application in Nanomedicine
Guo, Y., Li, W., Liu, S., Jing, D., Wang, Y., Feng, Q., Zhang, K., & Xu, J. (2022) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202100946 · Cited by 27 · see citing works
Gu, Z., Chen, H., Zhao, H., Yang, W., Song, Y., Li, X., Wang, Y., Du, D., Liao, H., Pan, W., et al. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2139369 · Cited by 27 · see citing works
The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma
Allami, P., Heidari, A., & Rezaei, N. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1083645 · Cited by 26 · see citing works
Nanotechnologies for enhancing cancer immunotherapy
Yang, J., Wang, C., Shi, S., & Dong, C. (2020) · Nano Research · doi:10.1007/s12274-020-2904-8 · Cited by 26 · see citing works
Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
Ding, J., Ding, X., Liao, W., & Lu, Z. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100913 · Cited by 26 · see citing works
Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases
Nguyen‐Thi, P., Nguyen, T. T., Phan, H. L., Ho, T.-T., Toi, V. V., & Giau, V. V. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105612 · Cited by 25 · see citing works
Brain Targeting Nanomedicines: Pitfalls and Promise
Käkinen, A., Jiang, Y., Davis, T. P., Teesalu, T., & Saarma, M. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s454553 · Cited by 24 · see citing works
Biomimetic nanomedicine toward personalized disease theranostics
Hao, H., Chen, Y., & Wu, M. (2020) · Nano Research · doi:10.1007/s12274-020-3265-z · Cited by 24 · see citing works
Recent progress on charge-reversal polymeric nanocarriers for cancer treatments
Sun, Q., Zhu, Y., & Du, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abffb5 · Cited by 24 · see citing works
Shetty, K., Yasaswi, S., Dutt, S., & Yadav, K. S. (2022) · 3 Biotech · doi:10.1007/s13205-022-03365-2 · Cited by 23 · see citing works
Challenges and material innovations in drug delivery to central nervous system tumors
Gong, Z., Zhou, D., Wu, D., Han, Y., Yu, H. Q., Shen, H., Feng, W., Hou, L., Chen, Y., & Xu, T. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123180 · Cited by 22 · see citing works
Recent Advances and Future Prospects in Biological-Membrane-Targeted Polymers
Chen, R., Liu, Y., Jiang, Y., Sun, M., Fan, Z., & Du, J. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.5c00014 · Cited by 22 · see citing works
Self-citationSmall Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
Teng, X.-Q., Qu, J., Li, G., Zhuang, H.-H., & Qu, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824299 · Cited by 22 · see citing works
Activatable luminescent probes for imaging brain diseases
Li, Z., Wang, C., Zhang, M., Li, S., Mao, Z., & Liu, Z. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101239 · Cited by 22 · see citing works
Advances in nanocarriers for targeted drug delivery and controlled drug release
Wang, Y., Huang, R., Feng, S., & Mo, R. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60861-2 · Cited by 22 · see citing works
Wu, Y., Zhong, D., Li, Y., Wu, H., Zhang, H., Mao, H., Yang, J., Luo, K., Gong, Q., & Gu, Z. (2021) · Nanoscale · doi:10.1039/d0nr08487e · Cited by 21 · see citing works
Wang, S., Yang, L., He, W., Zheng, M., & Zou, Y. (2024) · Small Methods · doi:10.1002/smtd.202400096 · Cited by 21 · see citing works
Self-citationZhang, W., Shen, J., Liang, J., Ge, C., Zhou, Y. C., Yin, L., & Ji, Y. I. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.032 · Cited by 20 · see citing works
Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer
Subhan, M. A., & Torchilin, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010153 · Cited by 19 · see citing works
Application of cell membrane-functionalized biomimetic nanoparticles in the treatment of glioma
Zhang, G., Yao, M., Ma, S., Zhang, K., Wang, Y., Wang, Z., Liang, J., Dai, S., Jin, R., & Guan, F. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00605k · Cited by 18 · see citing works
How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature
Yang, Y., Cheng, N., Luo, Q., Shao, N., Ma, X., Chen, J., Luo, L., & Xiao, Z. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s414736 · Cited by 18 · see citing works
Nanotechnology-enabled therapies improve blood-brain barrier challenges in brain tumor
Wenqi, Y., Lingxi, W., Mehmood, A., & Shah, W. (2023) · International Journal of Polymeric Materials · doi:10.1080/00914037.2023.2291105 · Cited by 18 · see citing works
Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases
Du, W., Zhou, L., Zhang, Q., Liu, X., Wei, X., & Li, Y. (2021) · Molecules · doi:10.3390/molecules26237340 · Cited by 18 · see citing works
Fu, L. L., Huo, S., Lin, P., Wang, J., Zhao, J., You, Y., Nie, X., & Ding, S. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.06.026 · Cited by 17 · see citing works
Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy
Yadav, P., Yadav, A. K., & Bhatia, D. D. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01120 · Cited by 16 · see citing works
Sun, H., Ma, W., Duan, S., Huang, J. L., Jia, R., Cheng, H., Chen, B., He, X., & Wang, K. (2021) · Chemical Science · doi:10.1039/d1sc03847h · Cited by 16 · see citing works
Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma
Panchal, K. N., Mutalik, S., & Manikkath, J. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06104-1 · Cited by 16 · see citing works
Recent advances in biomimetic nanodelivery systems for the treatment of depression
Jiang, P., & Li, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101781 · Cited by 16 · see citing works
- Authors
- Liu, Y., Zou, Y., Feng, C., Lee, A., Yin, J., Chung, R., Park, J. B., Rizos, H., Tao, W., Zheng, M., Farokhzad, O. C., & Shi, B.
- Affiliations
- Henan University (CN)
- Brigham and Women's Hospital (US)
- Macquarie University (AU)
- National Cancer Center (KR)
- Corresponding author
- Zheng, Meng
- Farokhzad, Omid C.
- Shi, Bingyang
- ORCID
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-02-03
- Volume
- 20
- Issue
- 3
- Pages
- 1637-1646
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W3004596160
- Cited by
- 162
- References
- 58
- Citations by year
- 2026: 6 · 2025: 26 · 2024: 29 · 2023: 31 · 2022: 28 · 2021: 32 · 2020: 10
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nano Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education of the People's Republic of China
- Ministry of Science and Technology of the People's Republic of China (2018YFA0209800)
- National Health and Medical Research Council (APP1111611, GNT1166024)
- China Postdoctoral Science Foundation (2017M620299)
- Macquarie University
- National Natural Science Foundation of China (31600809, 31640027, 51803049, U1604177)
- National Postdoctoral Program for Innovative Talents (BX201700070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- glioblastoma, RNA interference, siRNA delivery, charge conversion, erythrocyte membrane, blood-brain barrier penetration, core-shell nanocarriers, pH-responsive drug release, lysosomal enzyme release, tumor-targeted delivery, orthotopic tumor model
- MeSH terms
- Animals, Blood-Brain Barrier, Brain Neoplasms, Glioblastoma, Mice, Nude, Xenograft Model Antitumor Assays, RNA Interference, RNA, Small Interfering, Biomimetic Materials, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review